Lumibird shares fall after medical unit drags on Q1 results

Lumibird SA

28/04/2026 08:10

** French laser technology company Lumibird LBIRD.PA  shares fall around 8% after Q1 revenue comes in at 49.7 million euros ($58.15 million), up 0.7% Y/Y

** The medical unit slips 9.2%, hit by logistics disruption tied to the Middle East conflict, with Portzamparc citing a temporary shutdown at Adelaide's air freight hub and longer customs delays

** Broker says around 2 million euros of medical revenue was pushed into Q2, expecting a return to growth from H1 as logistics normalise and new products launch

** It notes the photonics division delivers a strong performance, up 11.3%, driven by defence and spatial markets, up 22%, alongside a sharp rise in the industrial and semiconductor segment, up 24%

** Share on track for its worst day since April 2025, when it closed 9.7 % lower

($1 = 0.8547 euros)

 (Reporting by Jerome Terroy)

 ((jerome.terroy@thomsonreuters.com))